Daniel Almonacid
94Patents
9h-index
64Co-inventors
73Inventor score
Filing activity: Oct 21, 2015 → Aug 4, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9710606B2 | Method and system for microbiome-derived diagnostics and therapeutics for neurological health issues | Emerging Cross-Sectional Technologies | 61 | Active |
| US9703929B2 | Method and system for microbiome-derived diagnostics and therapeutics | Emerging Cross-Sectional Technologies | 55 | Active |
| US10242160B2 | Method and system for microbiome-derived diagnostics and therapeutics | Emerging Cross-Sectional Technologies | 24 | Active |
| US9758839B2 | Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with microbiome functional features | Emerging Cross-Sectional Technologies | 16 | Active |
| US10169541B2 | Method and systems for characterizing skin related conditions | Emerging Cross-Sectional Technologies | 12 | Active |
| US10366793B2 | Method and system for characterizing microorganism-related conditions | Emerging Cross-Sectional Technologies | 11 | Active |
| US10381112B2 | Method and system for characterizing allergy-related conditions associated with microorganisms | Emerging Cross-Sectional Technologies | 9 | Active |
| US10073952B2 | Method and system for microbiome-derived diagnostics and therapeutics for autoimmune system conditions | Emerging Cross-Sectional Technologies | 9 | Active |
| US10246753B2 | Method and system for characterizing mouth-associated conditions | Emerging Cross-Sectional Technologies | 9 | Active |
| US10410749B2 | Method and system for microbiome-derived characterization, diagnostics and therapeutics for cutaneous conditions | Emerging Cross-Sectional Technologies | 8 | Active |
| US10325685B2 | Method and system for characterizing diet-related conditions | Emerging Cross-Sectional Technologies | 7 | Active |
| US10287639B2 | Method and system for microbiome analysis | Emerging Cross-Sectional Technologies | 5 | Active |
| US10381117B2 | Method and system for microbiome-derived characterization, diagnostics and therapeutics for cutaneous conditions | Emerging Cross-Sectional Technologies | 4 | Active |
| US10383519B2 | Method and system for microbiome-derived characterization, diagnostics and therapeutics for conditions associated with functional features | Emerging Cross-Sectional Technologies | 4 | Active |
| US10327641B2 | Method and system for microbiome-derived characterization, diagnostics and therapeutics for conditions associated with functional features | Emerging Cross-Sectional Technologies | 4 | Active |
| US10366789B2 | Method and system for microbiome-derived diagnostics and therapeutics for neurological health issues | Emerging Cross-Sectional Technologies | 4 | Active |
| US10395777B2 | Method and system for characterizing microorganism-associated sleep-related conditions | Emerging Cross-Sectional Technologies | 4 | Active |
| US10354756B2 | Method and system for microbiome-derived characterization, diagnostics and therapeutics for cutaneous conditions | Emerging Cross-Sectional Technologies | 4 | Active |
| US9760676B2 | Method and system for microbiome-derived diagnostics and therapeutics for endocrine system conditions | Emerging Cross-Sectional Technologies | 4 | Active |
| US10294532B2 | Method and system for microbiome analysis | Emerging Cross-Sectional Technologies | 3 | Active |
| US10357157B2 | Method and system for microbiome-derived characterization, diagnostics and therapeutics for conditions associated with functional features | Emerging Cross-Sectional Technologies | 3 | Active |
| US10415105B2 | Method and system for diagnostic testing | Chemistry; Metallurgy | 2 | Active |
| US10360346B2 | Method and system for microbiome-derived diagnostics | Emerging Cross-Sectional Technologies | 2 | Active |
| US10380325B2 | Method and system for microbiome-derived diagnostics and therapeutics | Emerging Cross-Sectional Technologies | 2 | Active |
| US10347362B2 | Method and system for microbiome-derived diagnostics and therapeutics for endocrine system conditions | Emerging Cross-Sectional Technologies | 2 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.